Working in Partnership with Physicians
1000 Doctors • 7000 Licensed Patients • 10 Years Experience
We understand the importance of evidence-based medicine. For this reason, we have entered into an exclusive partnership with Tikun Olam, one of the world leaders in medical cannabis production, research and patient treatment.
MedReleaf is the first and only medical cannabis producer in Canada to be officially certified an ISO 9001:2008 company, which means our superior QA practices are formally accredited by the prestigious, international governing authority. Our medical cannabis is produced using ‘clean-room technologies’, and our facility is designed to exceed Good Production Practices (GPP). Our monitoring begins at seed selection and continues throughout the growing, harvesting, trimming, drying and packaging phases.
Our Quality Assurance team is comprised of seasoned individuals with many years of experience in areas such as the manufacturing of biological implants, the implementation of hospital-grade laboratory technologies and the ethical collection of donated human tissues. These leading practices help to focus MedReleaf on patient safety, with an emphasis on the reporting, analysis, and prevention of medical errors.
At MedReleaf, we understand that health care providers depend on evidence to draw medical conclusions. This is why we are working to bring evidence-based results to the world. In partnership with Tikun Olam, MedReleaf is currently involved in over 20 scientific and clinical studies at world-class hospitals and research institutions. See below to read more about our exciting initiatives.Click Here to Read More About Our Research
Avidekel, Erez, Midnight. These are varieties that are only available in Canada through MedReleaf. This is important because these exclusive varieties have been consistently grown and used to treat thousands of patients over 10 years and are some of the most researched in the world.
Overview of the Science of Cannabis
Cannabis is a unique and complex plant containing medicinal properties that affect the endocannabinoid system found throughout the human body.
The active ingredients found within cannabis are known as cannabinoids. These compounds interact naturally with the human body’s own endocannabinoid system (ECS). This system of neuromodulators, CB1 and CB2 receptors and signaling pathways govern mood, movement, memory, appetite, pain and other functions.
The ECS is proving to be one of the most important physiological systems involved in establishing and maintaining human health. Endocannabinoids and their receptors are found throughout the body – in the brain, organs, connective tissues, glands and immune cells. Within each tissue type cannabinoids perform a variety of tasks with a constant objective – the maintenance of a stable internal environment despite fluctuations of the external environment, resulting in homeostasis.
The Endocannabinoid System
Cannabinoids exert many of their pharmacological effects by interacting with and modulating the human endocannabinoid system. This integrated system is comprised of a family of cannabinoid receptors, their endogenous activators (ligands), enzymes and transporters.
There are two types of cannabinoid receptors, CB1 and CB2. In addition, cannabinoids interact with other important neurotransmitter and neuromodulatory systems as well as TRP Channels.
The far-reaching pharmacology of cannabinoids explains why they hold such promise in diverse therapeutic areas.
Potential Therapeutic Uses
The strain that will work best for your patient depends on many factors – ultimately the right match will depend on the patient’s unique physical and mental responses to specific strains of cannabis.